Aarti Pharmalabs Ltd

NSE: AARTIPHARM · BSE: 543748 · Pharmaceuticals & Biotechnology · 13 announcements

Share price: ₹939.55
Market cap: ₹8,520 Cr
Revenue (annual): ₹1,819 Cr
Net profit (annual): ₹174.7 Cr
P/E (TTM): 40.0×Sector 50.4×
Promoter holding: 42.86%-0.22% QoQ
FII holding: 8.17%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Promoter Selling 4 Earnings Call 4 Financial Results 2 Management Change 1 Legal & Regulatory 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

2 Sep 2026 20:29 IST BSE

Legal & Regulatory

Aarti Pharmalabs Legal & Regulatory

Aarti Pharmalabs received an order from the Superintendent of Stamps, Gujarat, demanding ₹59.50 Crore for stamp duty and penalties related to a past demerger scheme.

Value: ₹59.50 Cr

Read the filing ↗